Molecular and Systems Pharmacology (GDBBS)


MD/PhD students are excluded from the Admissions entries, included in the enrollment entries (when they are enrolled in the LGS, as opposed to in the SOM), included in the number of degrees awarded (PhD only), and excluded from the time to degree and completion percentage entries.

Percentages are rounded to whole numbers and do not always add to 100.

PhD AdmissionsFall 2019Fall 20185 Year Average
Applications156105116
Admissions offers (Selectivity)19 (12%)16 (15%)16 (14%)
New doctoral students (Yield)6 (32%)7 (44%)7 (48%)
PhD EnrollmentFall 2019Fall 20185 Year Average
Total enrollment444242
Female48%43%46%
Male52%57%54%
International2%7%2%
U.S. citizen or permanent resident98%93%98%
PhD Enrollment, U.S. Citizen or
Permanent Resident, by Race
Fall 2019Fall 20185 Year Average
Black or African American12%8%8%
Asian9%8%7%
Hispanic of any race19%23%17%
American Indian or Alaska Native
Native Hawaiian or Other Pacific Islander1%
White60%62%62%
Two or more races
Not indicated5%
PhD Degrees and Completion2018-192017-185 Year Average
Number of degrees awarded576
Median years to PhD5.35.75.7
Average adjusted years to PhD5.15.55.7
Percent of students who entered
between 2007-08 and 2011-12, and
completed the PhD as
of August 31, 2019
73%